Canagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Canagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation

Published:2019-04-16 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Behnammanesh Ghazaleh,Durante Zane E.,Peyton Kelly J.,Martinez-Lemus Luis A.,Brown Scott M.,Bender Shawn B.,Durante William

Funder

American Diabetes Association

National Institutes of Health

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference59 articles.

1. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management;Beckman;JAMA.,2002

2. Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis;Birkeland;Lancet Diabetes Endocrinol.,2017

3. Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT-2) inhibitor, coadministered with sitagliptin in healthy volunteers;Brand;Adv. Ther.,2012

4. The pathobiology of diabetic complications;Brownlee;Diabetes,2005

5. Angiogenesis in atherosclerotic plaque;Camere;Redox Biol.,2017

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empagliflozin Attenuates Pulmonary Arterial Remodeling Through Peroxisome Proliferator-Activated Receptor Gamma Activation;ACS Pharmacology & Translational Science;2024-08-01

2. Endothelial Protection by Sodium-Glucose Cotransporter 2 Inhibitors: A Literature Review of In Vitro and In Vivo Studies;International Journal of Molecular Sciences;2024-07-02

3. Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation;Acta Pharmacologica Sinica;2024-05-08

4. Canagliflozin protects against hyperglycemia-induced cerebrovascular injury by preventing blood-brain barrier (BBB) disruption via AMPK/Sp1/adenosine A2A receptor;European Journal of Pharmacology;2024-04

5. SGLT2 Inhibitor Canagliflozin Alleviates High Glucose-Induced Inflammatory Toxicity in BV-2 Microglia;Biomedicines;2023-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3